145 related articles for article (PubMed ID: 37133471)
1. Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Marka A; Rodgers D; Zelaya Castillo L; Hoyt B; Chapman M; Carter J
J Drugs Dermatol; 2023 May; 22(5):507-508. PubMed ID: 37133471
[TBL] [Abstract][Full Text] [Related]
2. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
3. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
4. Intralesional 5-fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series.
Luu W; McRae MY
Australas J Dermatol; 2023 Nov; 64(4):556-559. PubMed ID: 37665127
[TBL] [Abstract][Full Text] [Related]
5. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Chitwood K; Etzkorn J; Cohen G
Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
[TBL] [Abstract][Full Text] [Related]
6. Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Hamad J; Jolly PS
Dermatol Ther; 2021 Nov; 34(6):e15139. PubMed ID: 34549487
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
Kurtis B; Rosen T
J Dermatol Surg Oncol; 1980 Feb; 6(2):122-7. PubMed ID: 7354186
[TBL] [Abstract][Full Text] [Related]
8. Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil.
Morse LG; Kendrick C; Hooper D; Ward H; Parry E
Dermatol Surg; 2003 Nov; 29(11):1150-3; discussion 1153. PubMed ID: 14641346
[TBL] [Abstract][Full Text] [Related]
9. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
10. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
Parker CM; Hanke CW
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
[TBL] [Abstract][Full Text] [Related]
11. A patient with squamous cell carcinoma
Vazquez T; Florez-White M
J Dermatolog Treat; 2020 Mar; 31(2):180-182. PubMed ID: 30843746
[No Abstract] [Full Text] [Related]
12. Intralesional 5-Fluorouracil in the Treatment of Lower Leg Squamous Cell Carcinoma.
Mackey M; Shahsavari A; Mackey VT
J Drugs Dermatol; 2018 Nov; 17(11):1241-1243. PubMed ID: 30500149
[TBL] [Abstract][Full Text] [Related]
13. Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review.
Metterle L; Nelson C; Patel N
J Am Acad Dermatol; 2016 Mar; 74(3):552-7. PubMed ID: 26577512
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
Doerfler L; Hanke CW
J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
[TBL] [Abstract][Full Text] [Related]
15. Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.
Seger EW; Tarantino IS; Neill BC; Wang T
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609455
[TBL] [Abstract][Full Text] [Related]
16. RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer.
Gil-Lianes J; Morgado-Carrasco D
Actas Dermosifiliogr; 2023 Mar; 114(3):255-256. PubMed ID: 36113608
[No Abstract] [Full Text] [Related]
17. Case Report of Multiple Keratoacanthomas and Squamous Cell Carcinomas in a Patient Receiving Pembrolizumab.
Chaudhari S; Leon A; Levin E; Neuhaus I; Liao W
J Drugs Dermatol; 2017 May; 16(5):513-515. PubMed ID: 28628690
[TBL] [Abstract][Full Text] [Related]
18. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
Kirby JS; Miller CJ
J Am Acad Dermatol; 2010 Oct; 63(4):689-702. PubMed ID: 20605654
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of keratoacanthoma with intralesional fluorouracil.
Goette DK; Odom RB
J Am Acad Dermatol; 1980 Mar; 2(3):212-6. PubMed ID: 7364978
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy With Intralesional Injections of 5-Fluorouracil and Topical Imiquimod.
Lindberg MR; DiLorenzo A; DeSimone JA
Cutis; 2023 Jan; 111(1):E19-E25. PubMed ID: 36947768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
